The slip
PARKINSON RECEIPTno. 6942
22 Oct 2026, 23:56 UTCdopamine neurons, braak
predictionIFNAR1 in dopamine neurons tracks Braak Lewy-body stage
registered9b1140aba3aaaed4
discovery-0.12 p=0.749 n=9
replication-0.52 p=0.149 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.12, p 0.749)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT85616bf24d99036462f20bf5…
follows 5c3af01f3a94…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6942: IFNAR1 in dopamine neurons, braak
- power
- full sample -0.28 (p 0.258, n 18), 95% CI -0.66 to +0.21. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.29 (p 0.250, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.26 (p 0.298, n 18). could be the mix.
- skeptic
- leave-one-out range -0.44 to -0.20, sign flips 0; without severely affected donors -0.28 (p 0.258, n 18). fragile.
- cell type
- strongest in oligodendrocytes: +0.61 (p 0.0069, n 18) vs -0.28 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IFNAR1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up IFNAR1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.18 p 0.534 (needs p < 3.0e-4)